Documentation scienceplus.abes.fr version Bêta

À propos de : Terminal ileal mucosal mast cells in irritable bowel syndrome        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Terminal ileal mucosal mast cells in irritable bowel syndrome
has manifestation of work
related by
Author
Abstract
  • Abstract. Terminal ileal biopsies were prospectively obtained and stained specifically for mast cells in 20 patients with irritable bowel syndrome (IBS) and 15 controls. The number of terminal ileal mast cells per high powered field (MC/HPF) (mean ±SEM) was 23.3±3.1 for, IBS and 6.8±1.1 for controls (P=0.0001). The diarrhea IBS subgroup had the greatest number of MC/HPF. No correlation was found between terminal ileal mucosal mast cell counts (MMCC) and the number of Manning criteria present or the functional bowel disease score (r=0.06 andr=−0.31, respectively). We conclude that terminal ileal MMCC are significantly elevated in a majority of patients with IBS. The mast cell may be responsible for the altered visceral perception found in the gastrointestinal tract in patients with IBS. The poor correlation of the MMCC to the clinical features of IBS may be the result of the dynamic state of the mast cell.
article type
publisher identifier
  • BF01303164
Date Copyrighted
  • 1993
Rights Holder
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata